menu

QuintilesIMS Blog

Fresh ideas and insights from our experts around the globe

distribution
Brazilians flock to pharmacies: How healthcare companies can bolster sales by embracing this shifting shopper trend
Filtered by 'Value' ×
Susan Abedi
Louise P
How emerging biopharma companies can use real-world evidence to demonstrate the value of their research efforts.
Read More
Jeremy Broadis
Obtaining regional and local market access in the age of health technology assessments.
Read More
DeanSummerfield
Exploring the challenges HTA bodies face keeping pace with fast track approval paths and value as defined by the patient.
Read More
Anke van Engen
Slow uptake of PCSK9 inhibitors offers valuable lessons to sponsors about the importance of hard clinical data to win approval from payers.
Read More
Anke van Engen
How this relatively new US-based HTA framework could change the conversation about value and affordability.
Read More
John Doyle
John Doyle
John Doyle
RickSax
An overview of the first workshop held by the President’s Cancer Panel on pricing, value, and innovation in cancer drug development.
Read More